Avella Specialty Pharmacy names new CEO

PHOENIX — Avella Specialty Pharmacy on Thursday named Rebecca Shanahan CEO. Shanahan brings more than two decades of successful leadership experience in the healthcare sector, as well as five years of service on Avella’s board of directors, to her new role. 

Shanahan will succeed John Musil in that capacity, though Musil will continue to actively serve as chairman, Avella stated, focusing on long-term strategy and serving as the company’s ambassador to the clinical community.   

“Avella has increased its revenue more than five-fold organically in the past five years and grown its operations correspondingly," Musil stated. "To fully capitalize on the opportunities resulting from our success and scale, Avella is fortunate to have Rebecca Shanahan taking on the role of chief executive officer. Not only does she bring a depth and breadth of healthcare, health plan and specialty pharmacy expertise that will be instrumental to Avella’s ongoing growth, but she already has a strong understanding of our organization through her years of participation on the board of directors.”   

Shanahan’s healthcare experience spans the provider sector. Earlier in her career, she served in executive roles at three health systems: as SVP business development for the University of Chicago Hospitals and Faculty Practice Plan; as SVP Methodist Medical Group and Ambulatory Services; and as general counsel of Community Hospitals of Indiana.  

From 1997 to 2005, Shanahan served as a board member, general counsel and EVP strategic initiatives for Priority Healthcare. From 2005 to 2007, Shanahan served as EVP and head of the Aetna Specialty Pharmacy. Since that time, she has provided consulting services to leading healthcare companies, including Cardinal Health, Shoppers Drug Mart, Bayer Pharmaceuticals, Bristol Myers Squibb, Rite Aid and Cancer Centers of Excellence.

“I am honored to be joining Avella at this exciting time,” Shanahan said. “The company has long been a leader and innovator in the development of unique specialty pharmacy services, with many well-deserved ‘best in class’ recognitions. I am excited about the opportunity to work with John, the board of directors, and the entire Avella team to continue to expand our clinical pharmacy, patient advocacy, and specialty pharmacy services into new disease categories and via new healthcare partnerships.”

 

 

Login or Register to post a comment.